Age-related changes in B and T lymphocytes and decline of humoral immune responsiveness in aged mice

1977 ◽  
Vol 6 ◽  
pp. 115-129 ◽  
Author(s):  
Diego Segre ◽  
Mariangela Segre
Blood ◽  
2002 ◽  
Vol 100 (6) ◽  
pp. 2257-2259 ◽  
Author(s):  
Lizet E. van der Kolk ◽  
Joke W. Baars ◽  
Martin H. Prins ◽  
Marinus H. J. van Oers

Abstract In lymphoma patients, treatment with chimeric CD20 monoclonal antibodies (rituximab) results in a depletion of normal and malignant B cells, persisting for 6 to 9 months. This B-cell depletion leads neither to a decrease in immunoglobulin levels nor an increase in the number of infectious complications. However, the effect of rituximab treatment on the immune responsiveness is unknown. In 11 patients with relapsed, low-grade lymphoma, we investigated the effect of rituximab treatment on the humoral immune response to 2 primary antigens and 2 recall antigens. After rituximab treatment, the humoral immune response to the recall antigens was significantly decreased when compared with the response before treatment. Already before rituximab treatment, none of these patients was able to mount a response to the primary antigens. These findings are relevant regarding the feasibility of rituximab in maintenance treatment and may also offer a rationale for the treatment of antibody-mediated autoimmune diseases with rituximab.


2020 ◽  
Vol 17 (1) ◽  
Author(s):  
S. S. Jeske ◽  
P. J. Schuler ◽  
J. Doescher ◽  
M. N. Theodoraki ◽  
S. Laban ◽  
...  

1981 ◽  
Vol 154 (2) ◽  
pp. 547-551 ◽  
Author(s):  
N R Klinman

Experiments were carried out to assess the role of naturally acquired antibody-specific immunoregulation in the immunodeficiency of aged individuals. It was found that greater than 50% of the primary dinitrophenyl-specific BALB/c B cells did not respond in carrier-primed 2-yr-old BALB/c adoptive hosts as compared with similarly primed younger recipients. Similar suppression was observed in carrier-primed younger BALB/c mice that had received 4 x 10(7) spleen cells from 2-yr-old BALB/c mice, as opposed to those that had received 4 x 10(7) spleen cells from younger mice. This diminution in responsiveness was noted only for syngeneic BALB/c B cells because B cells of strains differing from BALB/c in the heavy chain allotype-idiotype locus were not suppressed. These findings indicate that old, but not young, mice had developed the capacity to suppress primary B cells bearing receptors expressing much of the syngeneic antibody repertoire. This suppression may play an important causative role in the relatively poor humoral immune responsiveness of aged individuals.


1987 ◽  
Vol 61 (3) ◽  
pp. 916-920 ◽  
Author(s):  
M S Halpern ◽  
W S Mason ◽  
L Coates ◽  
A P O'Connell ◽  
J M England

2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Marija Holcar ◽  
Aleš Goropevšek ◽  
Alojz Ihan ◽  
Tadej Avčin

The dynamic process of the development of the immune system can in itself result in age-related immune malfunctions. In this study, we analysed lymphocyte subsets in the peripheral blood of 60 healthy donors, divided into groups of children, adolescents, and adults, focusing on effector (Teff) and regulatory (Treg) T lymphocytes and STAT1/STAT5 signalling response in helper T lymphocytes (Th) in adults, using flow cytometry. Our results demonstrate a decrease in the percentage of total Tregs and an increase in the percentage of total Teffs with age and a consequential immense increase in the Teff/Treg ratio. The increase of Teffs was most apparent in Th1, Th1Th17, and Th17CD161− subsets. Significant Th lymphocyte STAT1 expression differences were observed between children and adolescents, which were associated with the decrease in activated Tregs. Higher expression of STAT1 was found in FoxP3hi than in FoxP3low Th lymphocytes, while significant IL-2 induced STAT5 phosphorylation differences were found among the subsets of Th lymphocytes in adults. Our study demonstrates age-related changes in circulating Teff and Treg, as well as significant differences in STAT5/STAT1 signalling among FoxP3+ Th lymphocytes, providing new advances in the understanding of immunosenescence.


Sign in / Sign up

Export Citation Format

Share Document